Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bogner

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001
Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapyM Schmitz, G M Michl, R Walli, et al.
Waste Management (New York, N.Y.)|October 4, 2005
Methane mass balance at three landfill sites: what is the efficiency of capture by gas collection systems?K Spokas, J Bogner, J P Chanton, et al.
Blood|June 11, 1999
Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T cells: implications for acquired immunodeficiency syndrome-associated vasculopathyG Ascherl, C Hohenadl, O Schatz, et al.
Nuklearmedizin. Nuclear Medicine|October 1, 1988
[The place of 67Ga scintigraphy in the primary diagnosis and follow-up evaluation of opportunistic pneumonia in patients with AIDS]K Tatsch, P Knesewitsch, C M Kirsch, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 26, 1998
Cost-effectiveness analysis comparing liposomal anthracyclines in the treatment of AIDS-related Kaposi's sarcomaC L Bennett, R M Golub, T J Stinson, et al.
Klinische Monatsblatter Fur Augenheilkunde|September 1, 1992
[Differences in detectability of human immunodeficiency virus type 1 in tears and blood lymphocytes]S A Geier, L Gürtler, V Klauss, et al.
European Journal of Medical Research|April 17, 1999
Pneumocystis carinii pneumonia in the Federal Republic of Germany in the era of changing antiretroviral therapy - IDKF 13 -. German AIDS Study Group (GASG/IdKF)A Stoehr, K Arasteh, S Staszewski, et al.
HIV Medicine|May 17, 2024
Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studiesC Katlama, F Bisshop, J Bogner, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|September 24, 2014
[Cost of Illness of HIV Patients under Anteretroviral Therapy in Germany - Results of the 48-Week Interim Analysis of the Prospective Multicentre Observational Study 'CORSAR']A Kuhlmann, T Mittendorf, M Hower, et al.
HIV Medicine|February 2, 2018
Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in EuropeJ R Santos, A Cozzi-Lepri, A Phillips, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001
Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapyM Schmitz, G M Michl, R Walli, et al.
Waste Management (New York, N.Y.)|October 4, 2005
Methane mass balance at three landfill sites: what is the efficiency of capture by gas collection systems?K Spokas, J Bogner, J P Chanton, et al.
Blood|June 11, 1999
Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T cells: implications for acquired immunodeficiency syndrome-associated vasculopathyG Ascherl, C Hohenadl, O Schatz, et al.
Nuklearmedizin. Nuclear Medicine|October 1, 1988
[The place of 67Ga scintigraphy in the primary diagnosis and follow-up evaluation of opportunistic pneumonia in patients with AIDS]K Tatsch, P Knesewitsch, C M Kirsch, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 26, 1998
Cost-effectiveness analysis comparing liposomal anthracyclines in the treatment of AIDS-related Kaposi's sarcomaC L Bennett, R M Golub, T J Stinson, et al.
Klinische Monatsblatter Fur Augenheilkunde|September 1, 1992
[Differences in detectability of human immunodeficiency virus type 1 in tears and blood lymphocytes]S A Geier, L Gürtler, V Klauss, et al.
European Journal of Medical Research|April 17, 1999
Pneumocystis carinii pneumonia in the Federal Republic of Germany in the era of changing antiretroviral therapy - IDKF 13 -. German AIDS Study Group (GASG/IdKF)A Stoehr, K Arasteh, S Staszewski, et al.
HIV Medicine|May 17, 2024
Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studiesC Katlama, F Bisshop, J Bogner, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|September 24, 2014
[Cost of Illness of HIV Patients under Anteretroviral Therapy in Germany - Results of the 48-Week Interim Analysis of the Prospective Multicentre Observational Study 'CORSAR']A Kuhlmann, T Mittendorf, M Hower, et al.
HIV Medicine|February 2, 2018
Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in EuropeJ R Santos, A Cozzi-Lepri, A Phillips, et al.
Pageof 5